# US 2018/0000881 A1 · Phosphatidylserine-Containing Diet Supplement Aids With Melatonin Anti-Catabolic Dietary Nutrients

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0000881 A1
- Document ID: US20180000881A1
- Status: Published application
- Kind: A1
- Application number: 15/545,567
- Filed: 2016-01-22
- Published: 2018-01-04
- Earliest claimed: 2015-01-22
- Inventors: Bob Fritz
- Web page: https://patentgrep.com/patent/US20180000881A1

## CPC

- A61K 36/736: Prunus, e.g. plum, cherry, peach, apricot or almond
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/16: Inorganic salts, minerals or trace elements
- A23L 33/30: {Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence)}
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/006: {Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/14: Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)}
- A61K 9/20: Pills, tablets, {discs, rods (A61K9/0004, A61K9/0007, A61K9/0056, A61K9/0065 take precedence; for reconstitution of a drink A61K9/0095)}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 31/685: one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/286: Carthamus (distaff thistle)
- A61K 36/48: Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61P 17/00: Drugs for dermatological disorders
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/20: Hypnotics; Sedatives
- A61P 25/22: Anxiolytics
- A61P 25/24: Antidepressants
- A61P 27/02: Ophthalmic agents
- A61P 39/00: General protective or antinoxious agents
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

A supplement includes plant-derived phosphatidylserine in a physiologically beneficial amount and at least one plant-based concentrate or extract which promotes a melatonergic benefit.

## Claims

### Claim 1

A supplement, comprising:
phosphatidylserine; and
a tart cherry component.

### Claim 2 (depends on 1)

The supplement of claim 1, wherein the phosphatidylserine is a plant-derived phosphatidylserine.

### Claim 3 (depends on 1, 2)

The supplement of any one of claims 1-2, wherein the plant-derived phosphatidylserine is a soy-derived phosphatidylserine (“SDPS”).

### Claim 4 (depends on 1, 2, 3)

The supplement of any one of claims 1-3 wherein the phosphatidylserine constitutes between about 10% and about 35% by mass of the supplement.

### Claim 5 (depends on 1, 2, 3, 4)

The supplement of any one of claims 1-4, wherein the supplement includes about 30 mg to about 130 mg of SDPS.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The supplement of any one of claims 1-5, wherein the tart cherry component is any one of dried tart cherry, tart cherry powder, and tart cherry extract.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The supplement of any one of claims 1-6, wherein the tart cherry component constitutes between about 10% and about 70% by mass of the supplement.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The supplement of any one of claims 1-7, wherein the supplement includes about 30 mg to about 250 mg of tart cherry.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The supplement of any one of claims 1-8, further comprising divalent magnesium.

### Claim 10 (depends on 9)

The supplement of claim 9, wherein the divalent magnesium is supplied as an orotate salt.

### Claim 11 (depends on 9, 10)

The supplement of claim 9 or 10, wherein the divalent magnesium constitutes between about 20% and about 60% by mass of the supplement.

### Claim 12 (depends on 9, 10, 11)

The supplement of any one of claims 9-11, wherein the supplement includes about 70 mg to about 250 mg of divalent magnesium.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The supplement of any one of claims 1-12, further comprising a feverfew component.

### Claim 14 (depends on 13)

The supplement of claim 13, wherein the feverfew component constitutes between about 5% and about 20% by mass of the supplement.

### Claim 15 (depends on 13, 14)

The supplement of claim 13 or claim 14, wherein the supplement includes about 15 mg to about 100 mg of the feverfew component.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The supplement of any one of claims 1-15, further comprising a safflower seed component.

### Claim 17 (depends on 16)

The supplement of claim 16, wherein the safflower seed component constitutes between about 1% and about 30% by mass of the supplement.

### Claim 18 (depends on 14, 15)

The supplement of claim 14 or claim 15, wherein the supplement includes about 3 mg to about 110 mg of the safflower seed component.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The supplement of any one of claims 1-18, further comprising an encapsulant.

### Claim 20 (depends on 18)

The supplement of claim 18, wherein the encapsulant is selected from the group consisting of chitosan, cyclodextrin, cyclodextrin dendrimer, lecithin, and a plant protein.

### Claim 21

A diet supplement, comprising:
plant-derived phosphatidylserine in a physiologically beneficial amount; and
at least one plant-based concentrate or extract which promotes a melatonergic benefit.

### Claim 22 (depends on 21)

The diet supplement of claim 21, wherein the plant-derived phosphatidylserine is soy-derived phosphatidylserine.

### Claim 23 (depends on 21, 22)

The diet supplement of claim 21 or claim 22, wherein the physiologically beneficial amount of phosphatidylserine is of about 30 mg to about 130 mg

### Claim 24 (depends on 21, 22, 23)

The diet supplement of any one of claims 21-23, wherein the at least one plant-based concentrate or extract is of prunus cerasus.

### Claim 25 (depends on 24)

The diet supplement of claim 24, wherein the supplement includes about 30 mg to about 250 mg of prunus cerasus.

### Claim 26 (depends on 21, 22, 23, 24, 25)

The diet supplement of any one of claims 21-25, wherein the at least one plant-based concentrate or extract is of tanacetum parthenium.

### Claim 27 (depends on 26)

The diet supplement of claim 26 wherein the supplement includes about 15 mg to about 100 mg of tanacetum parthenium.

### Claim 28 (depends on 21, 22, 23, 24, 25, 26, 27)

The diet supplement of any one of claims 21-27, wherein the at least one plant-based concentrate or extract of carthamus tinctorius.

### Claim 29 (depends on 28)

The diet supplement of claim 28, wherein the supplement includes about 3 mg to about 110 mg of carthamus tinctorius.

### Claim 30 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29)

The diet supplement of any one of claims 21-29, wherein the phosphatidylserine and the at least one plant-based concentrate or extract are contained within a capsule.

### Claim 31 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

The diet supplement of any one of claims 21-30, wherein the phosphatidylserine and the at least one plant-based concentrate or extract are contained within a tablet.

### Claim 32 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The diet supplement of any one of claims 21-31, wherein the phosphatidylserine and the at least one plant-based concentrate or extract are contained within a liquid for oral administration.

### Claim 33 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The diet supplement of any one of claims 21-32, wherein the phosphatidylserine and the at least one plant-based concentrate or extract are contained within an edible bar.

### Claim 34 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The diet supplement of any one of claims 21-33, wherein the phosphatidylserine and the at least one plant-based concentrate or extract are contained within a powder.

### Claim 35 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The diet supplement of any one of claims 21-34 wherein the phosphatidylserine and the at least one plant-based concentrate or extract are contained within a topical medicament.

### Claim 36 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The diet supplement of any one of claims 21-35, wherein the phosphatidylserine and the at least one plant-based concentrate or extract are contained within a sublingual tablet or strip.

### Claim 37

A composition, comprising:
about 50% to about 70% of a magnesium component;
about 10% to about 30% soy-derived phosphatidylserine (SDPS);
about 5% to about 20% of a tart cherry component;
about 5% to about 15% of a feverfew component; and
about 1% to about 5% of a safflower seed component.

### Claim 38

A composition, comprising;
about 150 mg to about 250 mg of a magnesium component;
about 50 mg to about 100 mg soy-derived phosphatidylserine (SDPS);
about 25 mg to about 45 mg of a tart cherry component;
about 25 mg to about 45 mg of a feverfew component; and
about 1 mg to about 5 mg of a safflower seed component.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A method of treating a condition in a subject, comprising:
administering the supplement or composition of any one of claims 1-38 to the subject.

### Claim 40 (depends on 39)

The method of claim 39 wherein the condition is any one of jet lag, depression, weight loss, mood disorder, dysthymia, anxiety, seasonal affective disorder, sleep disorder, circadian rhythm disorder, light-induced sleep disruption, or a combination thereof.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A method of providing a healthful composition to a subject, comprising administering the composition, supplement or diet supplement of any of claims 1-38 to a subject.

### Claim 42 (depends on 41)

The method of claim 41, wherein the healthful composition is provided during at least one of physical training and dieting.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A method of promoting wellbeing in a subject, comprising:
providing the composition, supplement or diet supplement of any of claims 1-38; and
administering said composition, supplement, or diet supplement to the subject.

### Claim 44 (depends on 43)

The method of claim 43 wherein the wellbeing being promoted is wellbeing of at least one of eye health and digestion.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A method of regulating activity of at least one of tryptophan 1,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase 1 (IDO) in a subject, comprising:
administering the supplement or composition of any one of claims 1-38 to a subject.

### Claim 46 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A method of regulating cortisol in a subjecting, comprising:
administering the supplement or composition of any one of claims 1-38 to a subject.
